AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
9.91
-0.17 (-1.69%)
At close: Mar 20, 2026, 4:00 PM EDT
9.91
0.00 (0.00%)
After-hours: Mar 20, 2026, 5:00 PM EDT
AdaptHealth Stock Forecast
Stock Price Forecast
The 4 analysts that cover AdaptHealth stock have a consensus rating of "Strong Buy" and an average price target of $13.25, which forecasts a 33.70% increase in the stock price over the next year. The lowest target is $12 and the highest is $15.
Price Target: $13.25 (+33.70%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AdaptHealth stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +21.09% | Feb 26, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +51.36% | Nov 6, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +31.18% | May 12, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $14 → $13 | Buy | Maintains | $14 → $13 | +31.18% | May 8, 2025 |
| Baird | Baird | Buy Maintains $14 → $16 | Buy | Maintains | $14 → $16 | +61.45% | Feb 27, 2025 |
Financial Forecast
Revenue This Year
3.54B
from 3.24B
Increased by 9.00%
Revenue Next Year
3.78B
from 3.54B
Increased by 6.93%
EPS This Year
1.01
from -0.52
EPS Next Year
1.26
from 1.01
Increased by 23.92%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.7B | 4.0B | |
| Avg | 3.5B | 3.8B | |
| Low | 3.4B | 3.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.7% | 12.0% | |
| Avg | 9.0% | 6.9% | |
| Low | 3.9% | 1.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.24 | 1.51 | |
| Avg | 1.01 | 1.26 | |
| Low | 0.76 | 0.97 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 49.2% | |
| Avg | - | 23.9% | |
| Low | - | -4.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.